Emotional stress and reversible myocardial dysfunction

Cardiovascular Toxicology

Volumn 6, Issue 3-4, 2006, Pages 183-198

  Khanna, Deepak ^a   Kan, Hong ^a   Failinger, Conard ^a   Jain, Abnash C ^a   Finkel, Mitchell S ^a,b,c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ACUTE CORONARY SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; EMOTIONAL STRESS; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INFECTION; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRENATAL STRESS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION;

ANIMALS; CARDIOVASCULAR DISEASES; HEART; HUMANS; MODELS, CARDIOVASCULAR; MODELS, PSYCHOLOGICAL; RECOVERY OF FUNCTION; STRESS, PSYCHOLOGICAL;

EID: 33947160687     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:6:3:183     Document Type: Review

References (109)

1. Black, D.W. (1998). Iowa record-linkage study: death rates in psychiatric patients. J. Affect. Disord. 50:277-282.
2. Sutor, B., Rummans, T.A., Jowsey, S.G., et al. (1998). Major depression in medically ill patients. Mayo Clin. Proc. 73:329-337.
3. Lauzon, C., Beck, C.A., Huynh, T., et al. (2003). Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ 168:547-552.
4. Pignay-Demaria, V., Lesperance, F., Demaria, R.G., Frasure-Smith, N., and Perrault, L.P. (2003). Depression and anxiety and outcomes of coronary artery bypass surgery. Ann. Thorac. Surg. 75:314-321.
5. Anda, R., Williamson, D., Jones, D., et al. (1993). Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 4(4):285-294
6. Barefoot, J.C., Helms, M.J., Mark, D.B., et al. (1996). Depression and long-term mortality risk in patients with coronary artery disease. Am. J. Cardiol. 78(6):613-617.
7. Frasure-Smith, N., Lesperance, F., and Talajic, M. (1993). Depression following myocardial infarction. Impact on 6-month survival. JAMA 270:1819-1825.
8. Frasure-Smith, N., Lesperance, F., and Talajic, M. (1995). Depression and 18-month prognosis after myocardial infarction. Circulation 91(4):999-1005.
9. Wittstein, I.S., Thiermann, D.R., Lima, J.A.C., Baughman, K.L., Schulman, S.P., and Gerstenblith, G. (2005). Neurohumoral features of myocardial stunning due to sudden emotional stress. N. Engl. J. Med. 352:539-548.
10. Sharkey, S.W., Lesser, J.R., Zenovich, A.G., et al. (2005). Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 111(4):472-479.
11. Kurisu, S., Sato, H., Kawagoe, T., et al. (2002). Takotsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am. Heart J. 143(3):448- 455.
12. Glassman, A.H., Helzer, J.E., Covey, L.S., et al. (1990). Smoking, smoking cessation, and major depression. JAMA 264:1546-1549.
13. Ziegelstein, R.C., Fauerbach, J.A., Stevens, S.S., Romanelli, J., Richter, D.P., and Bush, D.E. (2000). Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med. 160:1818-1823.
14. Blumenthal, J.A., Williams, R.S., Wallace, A.G., Williams, R.B. Jr., and Needles, T.L. (1982). Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosomatic Med. 44:519-527.
15. Carney, R.M., Freedland, K.E., Eisen, S.A., Rich, M.W., and Jaffe, A.S. (1995). Major depression and medication adherence in elderly patients. Heath Psychol. 14:88-90.
16. DiMatteo, M.R., Giordani, P.J., Lepper, H.S., and Croghan, T.W. (2002). Patient adherence and medical treatment outcomes: a meta-analysis. Med. Care 40:794-811.
17. Lesperance, F., Frasure-Smith, N., Talajic, M., and Bourassa, M.G. (2002). Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105(9):1049-1053.
18. Libby, P. (2003). Vascular biology of atherosclerosis: overview and state of the art. Am. J. Cardiol. 91(3A):3A-6A.
19. Kan, H. and Finkel, M.S. (2003). Inflammatory mediators and reversible myocardial dysfunction. J. Cell. Physiol. 195:1-11.
20. Ignarro, L J., Buga, G.M., Wood, K.S., Byrns, R.E., and Chaudhuri, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. 84:9265-9269.
21. Rapoport, R.M., Draznin, M.B., and Murad, F. (1983). Endothelium- dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306:174-176.
22. Furchgott, R.F. and Zawadzki, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
23. Bruckdorfer, R. (2005). The basics about nitric oxide. Mol. Aspects Med. 26:3-31.
24. Ashley, E.A., Sears, C.E., Byrant, S.M., Watkins, H.S., and Casadei, B. (2002). Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 105:3011-3016.
25. Sears, C.E., Bryant, S.M., Ashley, E.A., et al. (2003). Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ. Res. 92:52-59.
26. Zaragoza, C., Ocampo, C., Saura, M., et al. (1998). The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc. Natl. Acad. Sci. 95:2469-2474.
27. Finkel, M.S., Oddis, C.V., Jacobs, T.D., Watkins, S.C., Hattler, B.G., and Simmons, R.L. (1992). Negative inotropic effects of cytokine on the heart mediated by nitric oxide. Science 257:387-389.
28. Anderson, T.J. (2003). Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Failure Reviews 8(1):71-86.
29. Ludmer, P.L., Selwyn, A.P., Shook, T.L., et al. (1986). Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315 (17):1046-1051.
30. Dixon, L.J., Morgan, D.R., Hughes, S.M., et al. (2003). Functional consequences of endothelial nitric oxide synthase uncoupling in congestive heart failure. Circulation 107(13):1725-1728.
31. Deten, A., Volz, H.C., Briest, W., and Zimmer, H.G. (2002). Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc. Res. 55:329-340.
32. Shan, K., Kurrelmeyer, K., Seta, Y., et al. (1997). The role of cytokines in disease progression in heart failure. Curr. Opin. Cardiol. 12:218-223.
33. Paine, E., Palmantier, R., Akiyama, S.K., Olden, K., and Roberts, J.D. (2000). Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J. Biol. Chem. 275:11,284-11,290.
34. Sugden, P.H. and Clerk, A. (1998). "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res. 83:345-352.
35. Kan, H., Xie, Z., and Finkel, M.S. (1999). TNF enhances NO production by neonatal rat cardiac myocytes through MAP kinase mediated activation of NFκB. Am. J. Physiol. 277(46):H1641-H1646.
36. Kan, H., Xie, Z., and Finkel, M.S. (2000). HIV gp120 enhances nitric oxide production by cardiac myocytes through p38 MAP kinase mediated NFκB activation. Am. J. Physiol. 279:H3138-3143.
37. Carroll, R. and Yellon, D.M. (2000). Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res. Cardiol. 95:243-249
38. Kan, H., Birkle, D., Jain, A.C., Failinger, C., Xie, S., and Finkel, M.S. (2005). P38 MAP Kinase inhibitor reverses stress-induced cardiac myocyte dysfunction. J. Appl. Physiol. 98(1):77-82
39. Kan, H., Xie, Z., and Finkel, M.S. (1999). Norepinephrine stimulated MAP kinase activity enhances cytokine induced nitric oxide production by neonatal rat cardiac myocytes. Am. J. Physiol. 276:H47-52.
40. Nakano, A., Baines, C.P., Kim, S.O., et al. (2000). Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart. Evidence for involvement of p38 MAPK. Circ. Res. 86:144-151.
41. Zhao, T.C., Hines, D.S., and Kukreja, R.C. (2001). Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial KATP channels. Am. J. Physiol. 280:H1278-H1285.
42. Braunwald, E. and Kloner, R.A. (1982). The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66:1146-1149.
43. Hattler, B.G., Gorcsan, J. III., Shah, N., et al. (1994). A potential role for nitric oxide (NO) in myocardial stunning. J. Card. Surg. 9:425-429.
44. Finkel, M.S., Hoffman, R.A., Shen, L., Oddis, C.V., Simmons, R.L., and Hattler, B.G. (1993). IL-6 as a mediator of stunned myocardium. Am. J. Cardiol. 71:1231-1232.
45. Guillen, I., Blanes, M., Gomez-Lechon, M.J., and Castell, J.V. (1995). Cytokine signaling during myocardial infarction: sequential appearance of IL-1beta and IL-6. Am. J. Physiol. 269:R229-R235.
46. Ikeda, U., Ohkawa, F., Seino, Y., et al. (1992). Serum interleukin 6 levels become elevated in acute myocardial infarction. J. Mol. Cell. Cardiol. 24:579-584.
47. Parillo, J.E. (1993). Mechanisms of disease: pathogenic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
48. Murry, C.E., Jennings, R.B. and Reimer, K.A. (1986). Preconditioning with ischemia a delay of cell injury in ischemic myocardium. Circulation 74:1124-1136.
49. Kloner, R.A., Shook, T., Przyklenk, K., et al. (1995). Previous angina alters in-hospital outcome in TIMI-4: a clinical correlate to preconditioning? Circulation 91:37-47.
50. Parratt, J.R. and Kane, K.A. (1994). KATP channels in ischaemic preconditioning. Cardiovasc. Res. 28:783-787.
51. Ping, P., Takano, H., Zhang, J., et al. (1999). Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ. Res. 84:587-604.
52. Xi, J., Jarrett, N.C., Hess, M.L., and Kukreja, R.C. (1999). Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation 99:2157-2163.
53. Bers, D.M. (2002). Cardiac excitation-contraction coupling. Nature 415:198-205.
54. Zaidi, N.F., Lagenaur, C.F., Abramson, J.J., Pessah, I., and Salama, G. (1989). Reactive Disulfides trigger Ca2++ release from sarcoplasmic reticulum via an oxidation reaction. J. Biol. Chem. 264(36):21,725-21,736.
55. Xu, L., Eu, J.P., Meissner, G., and Stamler, J.S. (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-s- nitrosylation. Science 279:234-236.
56. Finkel, M.S., Oddis, C.V., Romeo, R.C., and Salama, G. (1993). Positive inotropic effect of acetylcysteine in the cardiomyopathic Syrian hamster. J. Card. Pharm. 21:29-34.
57. Kan, H., Xie, Z., and Finkel, M.S. (2006). iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes. J. Mol. Cell. Cardiol. 40(1):131-137.
58. Cowan, M.J. (1995). Measurement of heart rate variability. West. J. Nurs. Res. 17:32-48.
59. Schwartz, P., La Rovere, M.T., and Vanoli, E. (1992). Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for postmyocardial infarction risk stratification. Circulation 85 (Suppl 1):77-91.
60. Gorman, J.M. and Sloan, R.P. (2000). Heart rate variability in depressive and anxiety disorders. Am. Heart J. 140:S77-S83
61. Krittayaphong, R., Casicio, W.E., Light, K.C., et al. (1997). Heart variability in patients with coronary heart disease: differences in patients with higher and lower depression scores. Psychosomatic Med. 59:231-235.
62. Carney, R.M., Saunders, R.D., Freedland, K.E., Stein, P., Rich, M.W., and Jaffe, A.S. (1995). Association of depression with reduced heart rate variability in coronary artery disease. Am. J. Cardiol. 76:562-564.
63. Yeragani, V.K., Pohl, R., Balon, R., et al. (1991). Heart rate variability in patients with major depression. Psychiatry Res. 37:35-46.
64. Lehofer, M., Moser, M., Hoehn-Saric, R., et al. (1997). Major depression and cardiac autonomic control. Biol. Psychiatry 42:914-919
65. Light, K.C., Kothandapani, R.V., and Allen, M.T. (1998). Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int. J. Psychophysiol. 28:157-166.
66. Hughes, J.W. and and Stoney, C.M. (2000). Depressed mood is related to high-frequency heart rate variability during stressors. Psychosomatic Med. 62:796-803.
67. Sloan, R.P., Shapiro, P.A., Bagiella, E., Myers, M.M., and Gorman, J.M. (1999). Cardiac autonomic control buffers blood pressure variability responses to challenge: a psychophysiologic model of coronary heart disease. Psychosomatic Med. 61:58-68.
68. Carney, R.M., Freedland, K.E., Rich, M.W., Smith, L.J., and Jaffe, A.S. (1993). Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am. J. Med. 95:23-28.
69. Kliks, R.B., Burgess, M.J., and Abildskov, J.A. (1975). Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am. J. Cardiol. 36:45-49.
70. Levine, S.P., Towell, B.L., Suarez, A.M., Knieriem, L.K., Harris, M.M, and George, J.N. (1985). Platelet activation and secretion associated with emotional stress. Circulation 71:1129-1134
71. Musselman, D.L., Toner, A., Manatunga, A.K., et al. (1996). Exaggerated platelet reactivity in major depression. Am. J. Psychiatry 153:1313-1317
72. Laghrissi-Thode, F., Wagner, W.R., Pollock, B.G., Johnson, P.C., and Finkel, M.S. (1997). Elevated platelet factor 4 and beta-thromboglolubin plasma levels in depressed patients with ischemic heart disease. Biol. Psychiatry 42:290-295.
73. Nemeroff, C.B. and Musselman, D.L. (2000). Are platelets the link between depression and ischemic heart disease? Am. Heart J. 140(4 Suppl):57-62.
74. Knuston, B., Wolkowitz, O.M., Cole, S.W., et al. (1998). Selective alteration of personality and social behavior by serotonergic intervention. Am. J. Psychiatry 155:373-379.
75. Kusumi, I., Koyama, T., and Yamashita, I. (1991). Serotonin stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol. Psychiatry 30:310-312.
76. Chrousous, G.P. and Gold, P.W. (1992). The concept of stress and stress system disorders: overview of physical and behavioral homeostatis. JAMA 267:1244-1252.
77. Adolphs, R., Tranel, D., Damasio, H., and Damasio, A.R. (1995). Fear and the human amygdala. J. Neurosci. 15:5879-5891.
78. Hariri, A.R., Mattay, V.S., Tessirtore, A., et al. (2002). Serotonin transporter genetic variation and the response of the human amygdale. Science 297(5580):400-403.
79. Nemeroff, C.B., Wilderlov, E., Bissette, G., et al. (1984). Elevated concentrations of CSF corticotropin releasing-factor like immunoreactivity in depressed patients. Science 226:1342-1344.
80. Veith, R.C., Lewis, L., Linares, O.A., et al. (1994). Sympathetic nervous system in major depression: basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51:411-422.
81. Krantz, D., Helmers, K., Bairey, C.N., Nebel, L.E., Hedges, S.M., and Rozanski, A. (1991). Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary heart disease. Psychosomatic Med. 53:1-12.
82. Jiang, W., Babyak, M., Krantz, D.S., et al. (1996). Mental stress-induced myocardial ischemia and cardiac events. JAMA 21:1651-1656.
83. Tafet, G. E., Idoyaga-Vargas, V.P., Abulafia, D.P., et al. (2001). Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression. Cogn. Affect. Behav. Neurosci. 1:388-393.
84. Burnett, A.L., Lowenstein, C.L., Bredt, D.S., Chang, T.S., and Snyder, S.H. (1992). Nitric oxide: a physiologic mediator of penile erection. Science 257(5068):401-403.
85. Krueger, J.M., Fang, J., Taishi, P., Chen, Z., Kushikata, T., and Gardi, S. (1998). Sleep: a physiologic role for IL-1 beta and TNF alpha. Ann. NY Acad. Sci. 856:148-159.
86. Nelson, R.J., Demas, G.E., Huang, P.L., et al. (1995). Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378(6555):383-386.
87. Ding, J.M., Chen, D., Weber, E.T., Faiman, L.E., Rea, M.A., and Gillett, M.U. (1994). Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 266(5191):1713-1717.
88. Kanai, A.J., Mesaros, S., Finkel, M.S., Oddis, C.V., Birder, L.A., and Malinshi, T. (1997). Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am. J. Physiol. 273(Cell Physiol 42):C1371-C137.
89. Meijer, A. (1985). Child psychiatric sequelae of maternal war stress. Acta Psychiat. Scand. 72:505-511.
90. Stott, D.H. (1973). Follow-up study from birth of the effects of prenatal stress. Develop. Med. Child Neurol. 15:770-787.
91. Ward, A.J. (1991). Prenatal stress and child psychopathology. Child Psychiat. Human Develop. 22:97-110.
92. Coplan, J.D., Andrews, M.W., Rosenblum, L.A., et al. (1996). Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA 93:1619-1623.
93. Fride, E. and Weinstock, M. (1988). Prenatal stress increases anxiety-related behavior and alters cerebral lateralization of dopamine activity. Life Sci. 42:1059-1065.
94. Fride, E., Dan, Y., Feldon, J., Halevy, G., and Weinstock, M. (1986). Effects of prenatal stress on vulnerability to stress in prepubertal and adult rats. Physiol. Behav. 37:681-687.
95. Weinstock, M., Poltyrev, T., Schorer-Apelbaum, D., Men, D., and McCarty, R. (1998). Effect of prenatal stress on plasma corticosterone and catecholamines in response to foot shock in rats. Physiol. Behav. 64:439-444.
96. Cratty, M.S., Ward, H.E., Johnson, E.A., Azzaro, A.J., Birkle, D.L. (1995). Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces. Brain Res. 675:297-302.
97. Weinstock, M. (1997). Does prenatal stress impair coping and regulation of hypothalamic- pituitary-adrenal axis? Neurosci. Biobehav. Rev. 21:1-10.
98. Ward, H.E., Johnson, E.A., Salm, A.K., and Birkle, D.L. (2000). Effects of prenatal stress on defensive withdrawal behavior and coticotropin releasing factor systems in rat brain. Physiol. Behav. 70:359-366.
99. Johnson, G.L. and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298(5600):1911-1912.
100. Communal, C., Colucci, W.S., and Singh, K. (2000). p38 mitogen-activated protein kinase-adrenergic pathway protects adult rat ventricular myocytes against receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J. Biol. Chem. 275:19,395-19,400.
101. Li, X., Qiu, J., Wang, J., Zhong, Y., Zhu, J., and Chen, Y. (2000). Corticosterone-incduced rapid phosphorylation of p38 and JK mitogen-activated protein kinases in PC 12 cells. FEBS Lett. 492:210-214.
102. Liao, P., Wang, S.Q., and Wang S. (2002). p38 mitorgen-activated protein kinase mediates negative inotropic effect in cardiac myocytes. Circ. Res. 90(2):190-196.
103. Salm, K., Pavelko, M., Krouse, E.M., Webster, W., Kraszpulski, M., and Birkle, D.L. (2004). Lateral amygdaloid nucleus expansion in adult rats is associated with exposure to prenatal stress. Brain Res. Dev. Brain Res. 148(2):159-167.
104. Hunt, S.A. (2005). ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 46(6):e1-82.
105. Oppenheimer, S.M. (1994). Neurogenic cardiac effects of cerebrovascular disease. Curr. Opin. Neurol. 7(1):20-24.
106. Wang, T.D., Wu, C.C., and Lee, Y.T. (1997). Myocardial stunning after cerebral infarction. Int. J. Cardiol. 58(3):308-311.
107. Port, J.D. and Bristow, M.R. (2001). Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell. Cardiol. 33(5):887-905.
108. Mongillo, M., Tocchetti, C.G., Terrin, A., et al. (2006). Compartmentalized phosphodiesterase-2 activity blunts b-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ. Res. 98:226-234.
109. Guck, T.P., Elsasser, G.N., Kavan, M.G., and Barone, E.J. (2003). Depression and congestive heart failure. Congest. Heart Fail. 9(3):163-169.